Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Divergent Cardiac and Renal Outcomes by Systolic Blood Pressure in HFrEF.

BACKGROUND Elevated systolic blood pressure (SBP) is associated with paradoxically lower mortality in heart failure with reduced ejection fraction (HFrEF), but whether this reflects underlying pathophysiology or residual confounding remains uncertain. Because higher SBP is also a risk factor for kidney failure, we test...

H. Sheriff, Q. Zeng-Treitler, John G. F. Cleland et al. · 0 citations
Review Oct 2026

Tirzepatide for Obstructive Sleep Apnea: Trial Evidence, Cardiometabolic Effects, and Implications for Cardiovascular Practice.

Obstructive sleep apnea affects approximately one billion adults worldwide and is associated with hypertension, atrial fibrillation, heart failure, and stroke. Obesity is its dominant reversible cause, yet positive airway pressure therapy splints the pharyngeal airway without addressing the adiposity that narrows it, a...

Fatima Safi Arslan, Rimsha Ahmad, W. Frishman et al. · 0 citations
Review Nov 2026

Drug-Coated Balloons Versus Drug-Eluting Stents in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis With Reconstructed Individual Patient Data and GRADE Assessment.

Patients with chronic kidney disease (CKD) undergoing percutaneous coronary intervention (PCI) face high ischemic and bleeding risks. Drug-coated balloons (DCB) avoid a permanent implant and permit shorter dual antiplatelet therapy. We searched PubMed, Embase, Scopus, and Web of Science through May 2026 for studies com...

A. M. Elbeny, M. Elkasaby, W. Ahmed et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.